arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

Profusa, Inc.

PFSA
$2.08 ▲ +0.18 (+9.47%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
21 Visible periods
23 Metrics
Peer-ranked Benchmarks
Price Chart
57
Health
Fair
Bullish
auto_awesome

Analytical Summary

Profusa, Inc. shows strong fundamentals with top-quartile Return on Common Equity (%). The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap —
Dividend Yield —
Revenue Growth —
Op. Margin —
ROIC 7.4% ↘
FCF / Share None
Trailing P/E —
Price / Book —
FCF Yield —
Debt / Equity —
info Valuation on last close. End-of-day price, Sep 23, 2026.

21-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-3.46M
↓ -208.6% —
FCF / Share Free cash flow per share
$-1.53
↓ -2090.9% —
Long-Term Debt Long-term obligations
$713.01K
↑ +92.9% —
trending_up

Bullish Indicators

  • Return on Common Equity (%)Return on Common Equity (%) is in the top quartile
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Returns
100
Financial Health
13
Cash Quality
38

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 5 years · 21 quarters